NCT04921046 is a Phase 4 clinical trial of lignocaine in Myoclonic Jerk, sponsored by Rawalpindi Medical College.

Who is sponsoring NCT04921046?

NCT04921046 is sponsored by Rawalpindi Medical College.

What drugs are being tested in NCT04921046?

Interventions in NCT04921046: lignocaine, Midazolam 1 milligram Prefilled Syringe.

What condition does NCT04921046 study?

NCT04921046 studies Myoclonic Jerk.

Is NCT04921046 still recruiting?

NCT04921046 is currently completed. Last updated 10 June 2021.

Last reviewed 2021-06-10 · How we verify

NCT04921046

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Effect of Pretreatment of Lignocaine Versus Midazolam in Prevention of Etomidate Induced Myoclonus.

Completed Phase 4 Last updated 10 June 2021

What this trial tests

Phase 4 trial testing lignocaine in Myoclonic Jerk in 224 participants. Completed in 30 June 2015.

Timeline

1 January 2015

Primary endpoint
30 June 2015

30 June 2015

Quick facts

Lead sponsor	Rawalpindi Medical College
Phase	Phase 4
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	double
Primary purpose	prevention
Enrollment	224
Start date	1 January 2015
Primary completion	30 June 2015
Estimated completion	30 June 2015

Drugs / interventions tested

lignocaine — full drug profile →
Midazolam 1 milligram Prefilled Syringe — full drug profile →

Conditions studied

Myoclonic Jerk — all drugs for Myoclonic Jerk →

Sponsor

Rawalpindi Medical College

Who can join

Adults 20 to 45, any sex, with Myoclonic Jerk. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study is a randomized control trial and it was conducted to compare the effectiveness of pretreatment with lignocaine versus midazolam on the frequency of myoclonus associated with etomidate induction. This was conducted in Holy Family Hospital Rawalpindi in a period of 6 months.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of lignocaine

Trials testing the same drug.

NCT04166578 — Analgetic Effect of Two Solutions of Intracameral Anesthesia During Cataract Surgery in Patients · completed

Other Rawalpindi Medical College trials

Trials by the same sponsor.

NCT07420127 — Comparison of Two Different Doses of Phenylephrine on Oxytocin Hemodynamic Effect · Phase 4 · recruiting
NCT07409688 — Pain Relief Following Laparoscopic Cholecystectomy While Comparing Intra Abdominal Versus Sub Cutaneous Local Anesthetic · Phase 4 · recruiting
NCT07088146 — Dexamethasone in Prolonging the Duration of Spinal Anesthesia Among Pregnant Patients · Phase 4 · recruiting
NCT07092943 — Driving Pressure Guided Mechanical Ventilation Versus Lung Protective Ventilation Among Patients Undergoing Elective Sur · NA · recruiting
NCT07078786 — Effect of Pre-delivery Dexamethasone in Comparison With Betamethasone on Fetal Heart Trace · Phase 4 · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04921046 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Rawalpindi Medical College
Last refreshed: 10 June 2021

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04921046.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing